跳至主要内容
临床试验/NCT04340440
NCT04340440已完成不适用

Surgical and Oncologic Outcomes After Curative D2 vs D1 Gastrectomy in Operable Gastric Carcinoma, A Randomized Controlled Study in Egyptian Population

University of Alexandria0 个研究点目标入组 80 人开始时间: 2014年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
80
主要终点
Postoperative morbidity rate

研究概览

简要总结

Gastric carcinoma is the second most common cause of cancer-related deaths and its main treatment modality if potentially curable is surgery but the optimal surgical resection is controversial. The aim of the current study was to assess the outcomes of curative D2 compared to D1 gastrectomy of operable gastric carcinoma regarding postoperative morbidity and mortality, disease recurrence and survival rates.

详细描述

80 consecutive patients with potentially operable gastric carcinoma were randomized via concealed envelopes into 2 groups (each included 40 patients), group I managed by radical gastrectomy with D1 lymphadenectomy while group II managed by radical gastrectomy with D2 lymphadenectomy . Both groups were compared regarding postoperative mortality, morbidities, tumor recurrence and 2 years survival rates.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

盲法说明

Randomization by opaque sealed envelopes

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Histologically confirmed gastric carcinoma
  • Potentially operable gastric carcinoma without evidence of distant metastasis

排除标准

  • Complicated gastric cancer (obstructed or perforated)
  • Locally irresectable tumor
  • Previous or coexisting cancer
  • Prior gastric surgery or neoadjuvant chemotherapy
  • Contraindication for major surgery

结局指标

主要结局

Postoperative morbidity rate

时间窗: 30 days after surgery

Frequency of early postoperative complications

Operative mortality rate

时间窗: Within 30 days after surgery

Frequency of early postoperative mortality

次要结局

  • 2 years Recurrence rate(2 years after surgery)
  • 2 years Cancer specific mortality rate(2 years after surgery)
  • 2 years Disease free survival rate(2 years after surgery)
  • 2 years Overall survival rate(2 years after surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohamed El Messiry

Ass. Professor

University of Alexandria

相似试验